ArticleScientific reports2026
DeCGAN: a diversity-enhanced CycleGAN for unpaired image-to-image translation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Unpaired image-to-image translation, demonstrated by frameworks like CycleGAN, has shown promise in critical applications, including medical imaging, but is hindered by challenges such as mode collapse and structural degradation. To address these, we propose DeCGAN, a Diversity-enhanced CycleGAN framework that integrates spectral normalisation with a novel composite loss function. This loss function combines structural consistency loss, leveraging high-level feature representations from a pre-trained VGG19 network, with mode-diversity loss to enhance both structural details and output diversity. Extensive evaluations on unpaired CT and MRI datasets demonstrate DeCGAN's superiority over state-of-the-art models. DeCGAN achieved Inception Scores (IS) of 2.44 (CT-to-MRI) and 3.94 (MRI-to-CT), marking a 75% improvement over CycleWGAN-GP. Structural fidelity metrics also showed SSIM scores of 0.94 (CT-to-MRI) and 0.98 (MRI-to-CT), and PSNR improvements of 11.9% and 17.4%, respectively. DeCGAN also exhibited robust diversity with higher LPIPS scores of 0.473 (CT-to-MRI) and 0.375 (MRI-to-CT), and consistently low FID scores (67 and 70). Statistical analysis confirms DeCGAN's significant gains in structural fidelity and diversity ([Formula: see text]). Qualitative evaluation by an expert radiologist confirmed the clinical relevance of the generated images, with 36.7% of CT and 33.3% of MRI images classified as real clinical images, and over 70% of these receiving high confidence scores (4-5 on a 5-point scale), demonstrating the presence of clinically relevant features. DeCGAN demonstrates consistent improvements over existing CycleGAN-based approaches, offering a balanced trade-off between diversity, structural fidelity, and clinical plausibility in unpaired CT-MRI translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.